Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ccell.2020.10.006 http://scihub22266oqcxt.onion/10.1016/j.ccell.2020.10.006 33086031!7547574!33086031     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33086031&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cancer+Cell 2020 ; 38 (5): 594-597 Nephropedia Template TP {{tp|p=33086031|t=2020. COVID-19: Staging of a New Disease |pdf=|usr=}}{{33086031}} gab.com Text COVID-19: Staging of a New Disease JO: Cancer Cell http://www.kidney.de/pget.php?&tw=1&pmid=33086031 #FOAvip Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is "metastasis," defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection. Twit Text FOAVip COVID-19: Staging of a New Disease ????Cancer Cell http://www.kidney.de/pget.php?&tw=1&pmid=33086031 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33086031 #FOAvip English Wikipedia <ref>{{Cite pmid|33086031}}</ref> COVID-19: Staging of a New Disease #MMPMID33086031 Cordon-Cardo C; Pujadas E; Wajnberg A; Sebra R; Patel G; Firpo-Betancourt A; Fowkes M; Sordillo E; Paniz-Mondolfi A; Gregory J; Krammer F; Simon V; Isola L; Soon-Shiong P; Aberg JA; Fuster V; Reich DL Cancer Cell 2020[Nov]; 38 (5): 594-597 PMID33086031show ga Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is "metastasis," defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection. |*Severity of Illness Index[MESH] |*Virus Internalization[MESH] |*Virus Replication[MESH] |Betacoronavirus/*isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/epidemiology/pathology/virology[MESH] |Humans[MESH] |Inflammation/*etiology/pathology[MESH] |Multiple Organ Failure/*etiology/pathology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/epidemiology/pathology/virology[MESH]COVID-19: Staging of a New Disease (epmc).pdf DeepDyve Pubget Overpricing